GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, HSD11B2, HSD17B2, HTR5A, IGF1R, MMP2, MMP9, PPARA, PTGES, RELA, SRC, TRPV1, TYR |
10.8879 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CDK6, CHRM1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR7, KDR, MAOA, MCL1, MET, PPARA, SRC, TNKS, TNKS2, TRPV1, XDH |
10.4505 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FLT3, HSD11B2, HTR5A, PTGES, RELA, SRC, TRPV1, TYR |
10.2647 |
[BP] GO:0010033 |
response to organic substance
|
ADRA1A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR5A, IGF1R, KDR, MCL1, MMP2, PPARA, PTGES, RELA, SRC, TRPV1, TYR |
10.2464 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MMP2, MMP9, PIM1, PTGES, RELA, SRC, XDH |
10.2464 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES, TBXAS1, TRPV1 |
10.2464 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
10.2464 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
10.2453 |
[BP] GO:0042221 |
response to chemical
|
ADRA1A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MCL1, MMP2, MMP9, PPARA, PTGES, RELA, SRC, TRPV1, TYR |
9.96292 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
9.86447 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, HTR5A, PTGES, RELA, SRC, TYR |
8.84505 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HSD17B3, HTR2A, HTR2B, HTR5A, KDR, MAP2K1, MCL1, MET, MMP2, MMP9, PIM1, PPARA, RELA, SIGMAR1, SRC, TNKS2, TYR |
8.69821 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CACNA1C, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SIGMAR1, SRC, TNKS, TNKS2, TRPV1 |
8.583 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC, TRPV1 |
8.49267 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
8.22373 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MCL1, MET, PTPN1, RELA, SRC, XDH |
8.21689 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA1A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, IGF1R, MMP2, PPARA, RELA, SRC, TRPV1 |
8.17046 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, ADRA1A, AKR1B1, ALPL, APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HSD17B3, HTR5A, KDR, MAP2K1, MCL1, MMP9, PIM1, PPARA, RELA, SIGMAR1, SRC, TYR |
8.12481 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, CDK6, DRD1, DRD2, DRD3, HTR2A, HTR2B, KDR, SRC, TNKS, TNKS2, TRPV1 |
8.12481 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
8.11146 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR6, HTR7 |
7.98998 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, BCL2, CACNA1C, CHRM1, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRB, F3, FABP4, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR7, IGF1R, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RELA, SRC, TNKS2, TRPV1, TYR |
7.85173 |
[BP] GO:0009725 |
response to hormone
|
ADRA1A, AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HTR5A, PPARA, RELA, SRC, TRPV1 |
7.84653 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM4, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.74649 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
7.66131 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR5A, HTR7 |
7.54435 |
[BP] GO:0048513 |
animal organ development
|
ACHE, ADRA1A, AR, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MAP2K1, PPARA, RELA, SRC, TYR |
7.51161 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AR, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, DRD2, DRD3, ESR1, F3, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MMP2, MMP9, PIM1, RELA |
7.46542 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PTPN1, RELA, SRC, XDH |
7.31103 |
[BP] GO:0007200 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, ESR1, HTR2A, HTR2B |
7.28541 |
[BP] GO:0042493 |
response to drug
|
ADRA1A, AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FABP3, HSD11B2, HTR2A, HTR2B, KDR, RELA, SRC, TRPV1 |
7.13604 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, GBA2, HSD17B3, HTR1A, MAOA, TYR |
7.10763 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
6.99134 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESRRA, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
6.91227 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD2, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A |
6.88133 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
6.88133 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.87528 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
6.87528 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
6.73964 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.67654 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.67654 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.67519 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FUT7, GBA2, HSD17B3, HTR2B, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH |
6.608 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, PTGES, RELA, SRC |
6.6022 |
[BP] GO:0006939 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
6.44459 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, HTR1A, MAOA, TYR |
6.40697 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SIGMAR1, SRC, TRPV1, XDH |
6.36511 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MCL1, MET, MMP9, PIM1, PTPN1, RELA, SIGMAR1, SRC, TRPV1, XDH |
6.32919 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, SRC |
6.03936 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MMP2, MMP9, PPARA, PTGES, PTPN1, RELA, SRC, TRPV1, TYR |
5.89001 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA1A, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, FLT3, HTR2A, HTR2B, MCL1, MET, SRC, TRPV1 |
5.84581 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.75042 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MCL1, MMP9, PIM1, PTPN1, RELA, SIGMAR1, SRC, TRPV1, XDH |
5.73923 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.66559 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HTR2A, HTR2B, SRC, TNKS, TNKS2, TRPV1 |
5.61192 |
[BP] GO:0097756 |
None
|
ADORA1, ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
5.46189 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.35979 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
5.35059 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
5.30583 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
5.30583 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APP, BCL2, CDK6, CHRM1, CHRM4, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, IGF1R, KDR, MET, MMP9, SRC |
5.25051 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA1A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
5.23437 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, HSD11B2, HTR2A, HTR2B, MMP2, PPARA, RELA, SRC, TRPV1, TYR |
5.23437 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, AR, DRD2, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
5.23437 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, TBXAS1, TYR, XDH |
5.23437 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APP, AR, AXL, BCL2, CA2, CA7, CACNA1C, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, F3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MET, MMP9, PPARA, PTPN1, SRC, TRPV1 |
5.18319 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
5.13145 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MCL1, MET, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
5.01033 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
4.97233 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.97233 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.97233 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA1A, APP, AR, AXL, BCL2, CA2, CACNA1C, CDK6, CHRM1, CHRM2, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MET, MMP9, PIM1, RELA, SRC, TNKS2, TRPV1, XDH |
4.95749 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA1A, AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, FABP4, HTR2A, HTR2B, MET, TRPV1 |
4.94031 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP2, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
4.93867 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA1A, APP, AR, AURKB, BCL2, CDC25B, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
4.91862 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC |
4.912 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, HTR1A, MAOA |
4.86855 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CHRM1, CHRM4, CYP1A1, ESR1, FLT3, HTR1A, MAP2K1, MET, PIM1, SRC, TYR |
4.82714 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.81649 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
4.79843 |
[BP] GO:0007154 |
None
|
ADORA1, ADRA1A, AR, AXL, BCL2, CACNA1C, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7, TRPV1 |
4.76076 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MET, MMP9, PIM1, PTPN1, RELA, SRC |
4.76076 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, TBXAS1 |
4.74879 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
4.73448 |
[BP] GO:0050801 |
ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, FABP3, HTR2A, HTR2B, TRPV1 |
4.72891 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, RELA, SRC |
4.71942 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, ESRRB, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
4.71138 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA1A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
4.71138 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, DRD3, ESRRB, FABP3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
4.68657 |
[BP] GO:0042310 |
None
|
ADRA1A, HTR1A, HTR2A, HTR2B, HTR7 |
4.67377 |
[BP] GO:0035265 |
organ growth
|
ADRA1A, AR, BCL2, CYP19A1, ESR1 |
4.6027 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, XDH |
4.59283 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
4.5689 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, TBXAS1 |
4.5689 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A, TRPV1 |
4.544 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA1A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TRPV1, XDH |
4.52749 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7, SRC |
4.51597 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, ADRA1A, CA2, CA7, DRD2 |
4.48112 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA1A, APP, AR, AXL, BCL2, CA2, CYP1B1, DRD2, DRD3, ESRRB, F3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MET, MMP9, PIM1, RELA, SRC, TRPV1 |
4.46963 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ADRA1A, BCL2, DRD2, DRD3, ESR1, IGF1R, MCL1, MET, MMP9, PTPN1, RELA, SRC, XDH |
4.46529 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA1A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
4.41603 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2B, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
4.41603 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HTR1A, HTR2B, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TYR, XDH |
4.41603 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA1A, APP, CA2, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1, SRC |
4.41603 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA1A, APP, AR, DRD2, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, PTPN1, SRC, XDH |
4.40878 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, TBXAS1 |
4.40087 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, DRD3, HTR1A, HTR2A, HTR2B |
4.39082 |
[BP] GO:0060402 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B, TRPV1 |
4.39082 |
[BP] GO:0007198 |
None
|
HTR1A, HTR5A, HTR7 |
4.38876 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38876 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, HTR6, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, XDH |
4.3537 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
4.33734 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
ADRA1A, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
4.23207 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD2, FABP3, FABP4, FUT7, GBA2, MET, PPARA, PTGES, TBXAS1 |
4.2285 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, HTR2B, IGF1R, KDR, MCL1, MMP9, PIM1, PTPN1, RELA, SRC |
4.21207 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA1A, APP, AR, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SRC, TNKS, XDH |
4.18061 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, RELA, SRC, TRPV1 |
4.16383 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.15482 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2, DRD3, HTR2A |
4.15482 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
4.13943 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, RELA, SRC, TRPV1, TYR |
4.1334 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, RELA, SRC, TRPV1 |
4.12885 |
[BP] GO:0030003 |
cellular cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
4.0819 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, HTR2A, MET, TRPV1 |
4.0819 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM4 |
4.04361 |
[BP] GO:0055074 |
calcium ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
4.033 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, ADRA1A, APP, CA2, CA7, DRD1, DRD2 |
4.02318 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
4.02318 |
[BP] GO:0060401 |
None
|
ADRA1A, CACNA1C, DRD2, HTR2A, HTR2B, TRPV1 |
4.01651 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MCL1, MET, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
4.01651 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APP, BCL2, CACNA1C, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
4.01292 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
3.99898 |
[BP] GO:0006873 |
cellular ion homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
3.99761 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA1A, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, HTR2A, HTR2B, HTR5A, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, PTPN1, RELA, SRC |
3.97418 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MET, PPARA, RELA, SRC, TNKS, TNKS2, TRPV1 |
3.9701 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.94233 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.94233 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
3.94233 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
3.94233 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
3.93817 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC, TNKS |
3.91022 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MCL1, MET, MMP9, PTPN1, RELA, SRC, XDH |
3.89345 |
[BP] GO:0023052 |
None
|
ADORA1, ADRA1A, AR, CACNA1C, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
3.89345 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA1A, AR, BCL2, DRD1, DRD2, DRD3, ESR1, ESR2, HTR2A, IGF1R, MCL1, MET, MMP9, PTPN1, RELA, SRC, XDH |
3.87743 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.86144 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
3.85099 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA1A, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, TNKS, XDH |
3.8415 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3, HTR2A |
3.83564 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
3.83481 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CACNA1C, CHRM1, DRD1, DRD2, DRD3, HTR1A, HTR2A, MMP9 |
3.81448 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM4 |
3.81448 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, DRD3, FABP3, FLT3, HSD11B2, IGF1R, MMP2, PPARA, RELA, SRC, TRPV1, TYR |
3.80827 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MMP2, MMP9, PTPN1, RELA, SRC, TRPV1 |
3.79948 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
3.79948 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, MAP2K1, SRC |
3.73631 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, MAP2K1, SRC |
3.69246 |
[BP] GO:0007267 |
None
|
ADORA1, ADRA1A, AR, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR2, HTR2A, HTR6, HTR7 |
3.69246 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, MAOA |
3.69093 |
[BP] GO:0055080 |
cation homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
3.68136 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, SRC, TRPV1 |
3.67125 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ADRA1A, APP, DRD2, HTR2A, HTR2B, KDR, MAP2K1, PTPN1, SRC |
3.64976 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
3.6362 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA1A, AR, BCL2, CDK6, CYP19A1, DRD1, DRD2, DRD3, ESR1, ESR2, IGF1R, MCL1, MET, MMP9, PPARA, PTPN1, RELA, SRC, XDH |
3.61257 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, MAP2K1, MMP2, MMP9, SRC |
3.59056 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, XDH |
3.58401 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, HTR2B, IGF1R, MAP2K1, MET, PPARA, RELA, SRC, TNKS, TNKS2, TRPV1 |
3.57347 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, DRD3, FABP3, PPARA, TRPV1 |
3.5671 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, KDR, RELA, SRC, TRPV1 |
3.56273 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CDK6, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, RELA, SRC, TRPV1 |
3.56273 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.55003 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, ESR1, HTR7, PPARA, SRC |
3.54226 |
[BP] GO:0008217 |
None
|
ADORA1, ADRA1A, AR, DRD2, DRD3, HSD11B2, PPARA |
3.52689 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
3.52388 |
[BP] GO:0003014 |
None
|
ADORA1, ADRA1A, AKR1B1, BCL2, DRD2, HSD11B2 |
3.52388 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, TNKS, XDH |
3.46368 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.45733 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.45733 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MMP9, SRC |
3.45704 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, HSD11B2, RELA, SRC |
3.44616 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.43962 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.43962 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, TBXAS1 |
3.43962 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, PTGES, TBXAS1 |
3.43962 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, PPARA, PTGES, TBXAS1 |
3.42601 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.39408 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR2A, HTR6, HTR7 |
3.39408 |
[BP] GO:0019725 |
cellular homeostasis
|
ADRA1A, APP, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, MCL1, TRPV1 |
3.38763 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, TNKS, TNKS2 |
3.36553 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CA7, CACNA1C, CHRM1, CYP19A1, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, MAP2K1, MMP9, PPARA, PTPN1, SRC, TRPV1 |
3.32026 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CHRM4, CSNK2A1, DRD2, F3, FLT3, IGF1R, KDR, MAP3K7, MCL1, MET, MMP2, MMP9, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1 |
3.31937 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.31726 |
[BP] GO:0006875 |
cellular metal ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
3.3104 |
[BP] GO:0071073 |
None
|
FABP3, HTR2A, HTR2B |
3.29035 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, BCL2, DRD2, DRD3, ESR1, IGF1R, KDR, MAP2K1, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.28161 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, RELA, SRC |
3.27697 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
3.27697 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA1A, CACNA1C, DRD1, DRD2, DRD3, HTR2B, HTR5A, KDR |
3.26193 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.25785 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, ADRA1A, APP, AR, BCL2, CDK6, CYP1B1, DRD2, FABP3, MAP2K1, PTGES, XDH |
3.23602 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.21707 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, MAP2K1, SRC |
3.21607 |
[BP] GO:0010038 |
response to metal ion
|
APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9, PTGES |
3.20171 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CDK6, CYP19A1, DRD2, ESR1, F3, FABP4, IGF1R, MAP2K1, MAP3K7, MCL1, MET, MMP2, PPARA, PTPN1, RELA, SRC, XDH |
3.20033 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PTPN1, SRC, TNKS, XDH |
3.19375 |
[BP] GO:0051282 |
None
|
CACNA1C, DRD1, DRD2, HTR2A, HTR2B, TRPV1 |
3.18243 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.16381 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
3.1593 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, DRD3, TNKS2 |
3.13402 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
3.13402 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SRC, XDH |
3.1308 |
[BP] GO:0007204 |
positive regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, TRPV1 |
3.11763 |
[BP] GO:0010863 |
positive regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
3.0655 |
[BP] GO:0002031 |
None
|
DRD2, DRD3, HTR2B |
3.04132 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
3.04132 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, HTR1A, MAOA, TRPV1 |
3.03775 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PTPN1, SRC |
3.00926 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, SRC |
2.99878 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
2.99815 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC |
2.99815 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.99593 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, SRC, TNKS |
2.98674 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AR, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HTR2B, IGF1R, KDR, MAP2K1, MCL1, MET, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
2.98674 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, HTR6 |
2.98308 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA1A, AKR1B1, APP, BCL2, CHRM1, CYP1B1, DRD1, DRD2, DRD3, HSD11B2, HTR1A, HTR2A, HTR2B, HTR7, SRC, TRPV1, TYR |
2.97219 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
2.95849 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA1A, APP, AR, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, XDH |
2.95849 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, SRC |
2.95181 |
[BP] GO:0003012 |
None
|
ADORA1, ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
2.95181 |
[BP] GO:1900274 |
regulation of phospholipase C activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.94385 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, PPARA, RELA, SRC, TRPV1 |
2.94194 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, FABP4, FUT7, GBA2, MAOA, MMP1, MMP2, MMP9, SRC, XDH |
2.93709 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC |
2.92383 |
[BP] GO:0055065 |
metal ion homeostasis
|
ADRA1A, APP, BCL2, CACNA1C, DRD1, DRD2, DRD3, ESR1, HTR2A, HTR2B, TRPV1 |
2.91397 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, DRD3, HTR2A |
2.9109 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.90438 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.90229 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.9005 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.88135 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PTPN1, SRC, TNKS |
2.87375 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, PTGES |
2.87038 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.87038 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA1A, APP, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, SRC, TNKS, XDH |
2.86148 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.86148 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.86148 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
ADRA1A, CA2, CA7 |
2.86148 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, DRD3, FABP3, FLT3, HTR2A, HTR2B, PPARA, SRC |
2.83702 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR2A, IGF1R, MAP2K1, MET, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2 |
2.82946 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, ESR1, F3, FABP4, KDR, MAP2K1, MET, PPARA, RELA |
2.82493 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PTPN1, SRC |
2.7917 |
[BP] GO:0006811 |
None
|
ADRA1A, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, FABP3, HTR2A, HTR2B, PPARA, TRPV1 |
2.78876 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
2.78181 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.77951 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.77445 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.77445 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.77445 |
[BP] GO:0051480 |
regulation of cytosolic calcium ion concentration
|
ADRA1A, CACNA1C, DRD1, DRD2, ESR1, HTR2A, HTR2B, TRPV1 |
2.76528 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, DRD3, RELA, TYR |
2.76528 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA1A, CACNA1C, CHRM1, CHRM2, DRD2, HTR2A |
2.76528 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, DRD3, HTR2A, PPARA |
2.74592 |
[BP] GO:0051781 |
None
|
AURKB, CDC25B, DRD2, DRD3, HTR2B |
2.74373 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, DRD2, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, SRC, TNKS |
2.74253 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, DRD2, DRD3, HTR2A, MMP9 |
2.73243 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, PPARA |
2.72911 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, F3, MET, SRC, XDH |
2.71779 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, BCL2, MCL1, MMP9, PTPN1, RELA, SRC |
2.71779 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC |
2.71256 |
[BP] GO:0051302 |
None
|
AURKB, CDC25B, DRD2, DRD3, ESRRB, HTR2B |
2.70575 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, PPARA, PTGES, TBXAS1 |
2.70106 |
[BP] GO:0050965 |
None
|
ADORA1, HTR2A, TRPV1 |
2.70106 |
[BP] GO:0050961 |
None
|
ADORA1, HTR2A, TRPV1 |
2.70106 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.70106 |
[BP] GO:0006936 |
None
|
ADRA1A, DRD1, DRD2, HTR2A, HTR2B, HTR7, TRPV1 |
2.68759 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, MAP3K7, PIM1, RELA |
2.65139 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, DRD3, HTR2A, MET |
2.64415 |
[BP] GO:0051283 |
None
|
DRD2, HTR2A, HTR2B, TRPV1 |
2.62947 |
[BP] GO:0051209 |
None
|
DRD2, HTR2A, HTR2B, TRPV1 |
2.62947 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, MCL1, SRC |
2.62722 |
[BP] GO:0071071 |
None
|
FABP3, HTR2A, HTR2B |
2.62722 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM4 |
2.62722 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.62722 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.62722 |
[BP] GO:0019933 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.60755 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD1, DRD2, DRD3, HTR2B, SRC, TRPV1 |
2.56583 |
[BP] GO:0042391 |
None
|
ADORA1, ADRA1A, APP, BCL2, CACNA1C, DRD1, KDR, SRC, TRPV1 |
2.56232 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.54911 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.52999 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MCL1, MMP9, PTPN1, SRC |
2.52383 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HTR2A, HTR2B, IGF1R, MAP2K1, MAP3K7, PTPN1, SRC |
2.51705 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.50625 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.50625 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50625 |
[BP] GO:0007568 |
aging
|
ADRA1A, AURKB, BCL2, CYP1A1, HTR2A, MAP2K1, RELA |
2.50382 |
[BP] GO:0010518 |
positive regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.5028 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.48442 |
[BP] GO:0014821 |
None
|
DRD1, DRD2, HTR2B |
2.48442 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CDC25B, CDK6, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, HTR2B, KDR, MAP2K1, MCL1, MET, MMP2, MMP9, SRC |
2.47932 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, DRD2, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, SRC |
2.47932 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
2.47435 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ADRA1A, ALPL, AXL, BCL2, CDK6, CHRM2, CYP1A1, CYP1A2, DRD3, HSD11B2, HTR2A, PTGES, RELA, SRC, TRPV1, TYR |
2.45955 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
2.45487 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA1A, CACNA1C, CHRM1, CHRM2, DRD2, DRD3, HTR2A, TRPV1 |
2.45093 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SRC |
2.45093 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AR, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HTR2B, IGF1R, MCL1, MET, MMP9, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
2.44817 |
[BP] GO:0019935 |
None
|
ADRA1A, DRD1, DRD2, DRD3, HTR5A |
2.43959 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, MAP2K1, MAP3K7, MCL1, MMP2, MMP9, PPARA, PTGES, PTPN1, RELA, SRC, TRPV1 |
2.43165 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.42732 |
[BP] GO:0016048 |
None
|
ADORA1, HTR2A, TRPV1 |
2.42732 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.42732 |
[BP] GO:0048732 |
gland development
|
AR, BCL2, CSNK2A1, CYP19A1, MAP2K1, RELA, TYR |
2.39867 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, SRC, TNKS |
2.39681 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.39209 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.39209 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, BCL2, MCL1, RELA, SRC |
2.38857 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.36594 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HSD11B2, RELA, SRC, TRPV1, TYR |
2.34506 |
[BP] GO:0031623 |
None
|
ACHE, DRD2, DRD3, HTR2B |
2.33423 |
[BP] GO:0040007 |
None
|
ADRA1A, APP, AR, BCL2, CYP19A1, ESR1, SRC, TNKS2 |
2.33106 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, PPARA, TRPV1 |
2.32745 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.31768 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.30805 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.30805 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, MMP9, RELA, SRC |
2.28447 |
[BP] GO:0097553 |
None
|
DRD2, HTR2A, HTR2B, TRPV1 |
2.28244 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, DRD2, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, SRC |
2.28244 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.28151 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, RELA, SRC |
2.25928 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.25928 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.25928 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25928 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25928 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, PPARA |
2.24938 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, BCL2, CSNK2A1, ESRRB, HTR2A, HTR2B, KDR, MAP3K7, MCL1, MET, PPARA, PTPN1, RELA |
2.24722 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA1A, AR, BCL2, DRD2, DRD3, ESR1, ESR2, IGF1R, MCL1, MET, MMP9, PTPN1, RELA, SRC, XDH |
2.24136 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.24136 |
[BP] GO:0010517 |
regulation of phospholipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.24136 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.24136 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, FLT3, HTR2A, HTR2B, MAP2K1, MAP3K7, PTPN1, SRC |
2.23549 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.217 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, HTR2B, MCL1, MET, PPARA, RELA |
2.217 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, MCL1, SRC |
2.217 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM4 |
2.217 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.217 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.217 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM4 |
2.217 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, AXL, CYP1B1, RELA |
2.19502 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.192 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, AR, DRD1, ESR1, FLT3, IGF1R, MMP2, RELA, SRC, TRPV1 |
2.18328 |
[BP] GO:0060193 |
positive regulation of lipase activity
|
ADRA1A, ESR1, HTR2A, HTR2B |
2.17049 |
[BP] GO:0007202 |
None
|
ADRA1A, HTR2A, HTR2B |
2.16641 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.16641 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, DRD3, ESR1, ESRRA, ESRRB, F3, HTR2A, KDR, MAP2K1, PIM1, PPARA, RELA, SRC, TNKS2, TRPV1, XDH |
2.14543 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CHRM1, DRD1, DRD2, DRD3, HTR2A |
2.13608 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MAP2K1, MET, PPARA, RELA, SRC, TNKS, TNKS2 |
2.12618 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, RELA |
2.12561 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.12475 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.11173 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA1A, CHRM1, DRD1, HTR1A, HTR2A, HTR2B, HTR7 |
2.10866 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA1A, CHRM1, CHRM2 |
2.10152 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, PTGES, RELA, SRC |
2.09531 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, MMP9, RELA, SRC |
2.09001 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.08476 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.08476 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.08476 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.08476 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.08476 |
[BP] GO:0071502 |
None
|
HTR2B, TRPV1 |
2.08476 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.08476 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.08476 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.08476 |
[BP] GO:0010513 |
None
|
HTR2A, HTR2B |
2.08476 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.08476 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3 |
2.08476 |
[BP] GO:0034097 |
response to cytokine
|
AXL, BCL2, FABP4, FLT3, MCL1, PTGES, RELA, SRC, TRPV1 |
2.08228 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA1A, AKR1B1, APP, AR, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CDC25B, CDK6, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, XDH |
2.07845 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PTPN1, RELA, SRC |
2.0697 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.0697 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
2.0678 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, BCL2, CA2, CA9, ESR1, MET, SRC |
2.0678 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA1A, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HTR1A, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MCL1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SRC, TNKS, TNKS2, TRPV1, XDH |
2.06658 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.05131 |
[BP] GO:0032465 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.05131 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.04713 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM4 |
2.04713 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, HTR2B, SRC, TRPV1 |
2.03585 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HSD17B3 |
2.03045 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.02935 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.00812 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, ESR1, HSD17B3 |
2.00566 |
[BP] GO:0014059 |
None
|
DRD2, DRD3, HTR2A |
2.00566 |
[BP] GO:0070371 |
None
|
HTR2B, KDR, MAP2K1 |
2.00566 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALOX5, ALPL, APP, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MCL1, MET, MMP2, PIM1, PTGES, PTPN1, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR |
7.09826 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA4, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
6.6022 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
5.61192 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, PTGES, PTPN1, SIGMAR1, SRC, TBXAS1, TRPV1, TYR |
4.93867 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, CSNK2A1, DRD1, DRD2, DRD3, ESR1, F3, FLT3, GBA2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SRC, TRPV1 |
4.92346 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA1A, APP, AXL, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, SRC, TRPV1 |
4.12885 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA1A, AKR1B1, AKR1B10, ALOX5, AOX1, APP, AR, AURKB, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, HTR2A, HTR5A, KDR, MAOA, MAP2K1, MAP3K7, MCL1, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, SIGMAR1, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
3.74378 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.43962 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, PTPN1, SIGMAR1, TBXAS1 |
3.32851 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, GBA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTGES, SIGMAR1, TBXAS1 |
3.30134 |
[CC] GO:0031224 |
None
|
ACHE, ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, PTGES, SIGMAR1, TBXAS1, TRPV1, TYR |
3.24834 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CYP19A1, CYP2D6, FLT3, GBA2, HSD17B3, HTR5A, KDR, MAP2K1, PTPN1, SIGMAR1, XDH |
3.19636 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA1A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM4, DRD1, DRD2, HTR2A, MET, SIGMAR1, SRC, TRPV1 |
3.01993 |
[CC] GO:0016021 |
None
|
ADORA1, ADORA3, ADRA1A, ALPL, APP, AXL, CA12, CA14, CA9, CACNA1C, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, F3, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAOA, MCL1, MET, PTGES, SIGMAR1, TBXAS1, TRPV1, TYR |
2.82755 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, CHRM1, CHRM2, CHRM4, DRD2, SIGMAR1, SRC, TRPV1 |
2.12521 |
[CC] GO:0014069 |
None
|
ADORA1, CACNA1C, CHRM1, DRD2, SIGMAR1, SRC |
2.06393 |
[CC] GO:0099572 |
None
|
ADORA1, CACNA1C, CHRM1, DRD2, SIGMAR1, SRC |
2.06393 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TYR, XDH |
11.5476 |
[MF] GO:0008227 |
None
|
ADRA1A, CHRM1, CHRM2, CHRM4, DRD2, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
11.2226 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, SRC, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
10.4684 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.2464 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM4, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
10.2023 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1, TRPV1 |
9.88864 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.8529 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, PPARA, SIGMAR1, TRPV1 |
9.17832 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CDK6, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1, TRPV1 |
9.13504 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA1A, AR, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, PPARA, SIGMAR1, TRPV1 |
8.70506 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
7.86976 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, MAP3K7, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
7.66131 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, FLT3, HTR2A, HTR2B, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, SIGMAR1, SRC, TRPV1 |
7.13604 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.6879 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
6.6879 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.67654 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7 |
6.67654 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, MMP9, PIM1, PTGES, PTPN1, SRC, TBXAS1, TNKS, TNKS2, TYR, XDH |
6.67654 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MAOA, TBXAS1, TYR, XDH |
6.48539 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
6.48539 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA1A, AXL, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, F3, FLT3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, IGF1R, KDR, MET, SIGMAR1, TRPV1 |
6.48539 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, SHBG |
6.08247 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.04532 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
5.80568 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, XDH |
5.25051 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.1939 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP2, MMP9, PPARA, PTPN1, TNKS |
5.10049 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
5.09354 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.94641 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.94641 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.86855 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR2B, HTR5A, HTR7 |
4.82714 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.79843 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.67377 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
4.61823 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA |
4.56188 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, ADRA1A, CHRM1, CHRM2, CHRM4, DRD1, DRD2, DRD3, HTR1A, HTR2A, HTR2B, HTR5A, HTR6, HTR7, SIGMAR1 |
4.12885 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.05962 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM4 |
4.04361 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, SHBG, TRPV1 |
4.01779 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, HSD11B2, HSD17B1, PTGES, SRC, TBXAS1, XDH |
4.01779 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
3.89666 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
3.86144 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, SRC, TBXAS1 |
3.71461 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, MMP1, MMP2, MMP9, PIM1, PPARA, PTPN1, TBXAS1, TNKS, TNKS2, TRPV1, TYR, XDH |
3.46816 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TBXAS1, TYR |
3.43962 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.27697 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MAP2K1, MET, SRC |
3.05719 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.01866 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
2.94385 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.90403 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.90229 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.90229 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.86148 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.85163 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, HSD17B1, IGF1R, SHBG |
2.72407 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, ESR1, ESR2, FLT3, IGF1R, KDR, MAP3K7, MCL1, MET, MMP9, RELA, TRPV1, TYR, XDH |
2.67031 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.66349 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM4 |
2.48442 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, RELA, SRC |
2.47076 |
[MF] GO:1901338 |
None
|
DRD1, DRD2, DRD3 |
2.36594 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.30181 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FLT3, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR2B, HTR5A, HTR7, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, PPARA, PTPN1, RELA, SHBG, SRC, TBXAS1, TRPV1, XDH |
2.27258 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KDR, MAP2K1, MAP3K7, MET, PIM1, SRC |
2.26083 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25928 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.25928 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP9, PPARA, PTPN1, RELA, SRC |
2.23011 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.08476 |
[MF] GO:0051434 |
BH3 domain binding
|
BCL2, MCL1 |
2.08476 |